Skip to content

Individual factors associated with vaccine reactogenicity - a randomised controlled trial in young women aged 14 - 26

Injection technique and individual characteristics associated with local reactogenicity to quadrivalent human papillomavirus vaccine in young women

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000395033
Acronym
FAR Trial
Enrollment
450
Registered
2010-05-17
Start date
2009-09-22
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine characteristics of vaccination technique & individuals which are associated with severity of common adverse events following immunisation.

Interventions

Participants will be randomised to receive one of the three injection techniques below: 1. Fast without aspiration – Administration into the deltoid at 90 degrees. This involves a rapid plunge, no aspiration, & withdrawal of the needle following immunisation lasting less than 1 second. 2. Slow with aspiration – Administration into the deltoid at 90 degrees. This involves a slow plunge, aspiration, & slow withdrawal of the needle following immunisation over a period lasting 5-10 seconds and 3.

Participants will be randomised to receive one of the three injection techniques below: 1. Fast without aspiration – Administration into the deltoid at 90 degrees. This involves a rapid plunge, no aspiration, & withdrawal of the needle following immunisation lasting less than 1 second. 2. Slow with aspiration – Administration into the deltoid at 90 degrees. This involves a slow plunge, aspiration, & slow withdrawal of the needle following immunisation over a period lasting 5-10 seconds and 3. Slow without asperation - Administration into the deltoid at 90 degrees. This involves a slow plunge, no aspiration, & slow withdrawal of the needle following immunisation over a period lasting 5-10 seconds.

Sponsors

Uniservices and University of Auckland
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
14 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy girls and women aged between 14 and 26 years of age.

Exclusion criteria

Contraindication to receiving gardasil vaccine or unwell on the day of vaccination without a regualr telephone or who do not speak English

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026